Epigenetics: The Science of Change
What is epigenetics?
DNA modifications that do not change the DNA sequence can affect gene activity. Chemical compounds that are added to single genes can regulate their activity; these modifications are known as epigenetic changes. The epigenome comprises all of the chemical compounds that have been added to the entirety of one’s DNA (genome) as a way to regulate the activity (expression) of all the genes within the genome. The chemical compounds of the epigenome are not part of the DNA sequence, but are on or attached to DNA (“epi-“ means above in Greek). Epigenetic modifications remain as cells divide and in some cases can be inherited through the generations. Environmental influences, such as a person’s diet and exposure to pollutants, can also impact the epigenome.
Access Full PDF >>
Epigenetic changes can help determine whether genes are turned on or off and can influence the production of proteins in certain cells, ensuring that only necessary proteins are produced. For example, proteins that promote bone growth are not produced in muscle cells. Patterns of epigenetic modification vary among individuals, different tissues within an individual, and even different cells.
A common type of epigenetic modification is called DNA methylation. DNA methylation involves attaching small molecules called methyl groups, each consisting of one carbon atom and three hydrogen atoms, to segments of DNA. When methyl groups are added to a particular gene, that gene is turned off or silenced, and no protein is produced from that gene.
Because errors in the epigenetic process, such as modifying the wrong gene or failing to add a compound to a gene, can lead to abnormal gene activity or inactivity, they can cause genetic disorders. Conditions including cancers, metabolic disorders, and degenerative disorders have all been found to be related to epigenetic errors.
Scientists continue to explore the relationship between the genome and the chemical compounds that modify it. In particular, they are studying what effect the modifications have on gene function, protein production, and human health.
The epigenetics operating in the across the globe includes Merck KGaA, Thermo Fisher Scientific, Inc., Abcam plc, Agilent Technologies, Active Motif, QIAGEN, Bio-Rad Laboratories, Inc., PerkinElmer Inc., New England Biolabs (NEB), and Illumina, Inc. among others.
For instance, in February, 2018 QIAGEN launches epigenetic breast cancer test in Europe. In November 2015 Abcam acquires AxioMx to access new growth opportunities and extend antibody leadership. Thus expanding its business in global epigenetics market.
Want To Know More about epigenetics...??
ASK FOR 150 PAGES PDF OF THIS STUDY
Reference
- ghr.nlm.nih.gov
- theinsightpartners.com